1Q21 Investor Update
2021 PRIORITIES & AREAS OF FOCUS
Tobacco Franchise
Hemp/Cannabis
& Third Plant-based
Franchise
Financial
01
03
05
■
■
■
Secure MRTP Authorization from FDA
Fully prepared for commercial launch of
VLNⓇ within 90 days post authorization
Execute on licensing and partnership
initiatives
■ Target upstream segments of cannabinoid
value chain
■
Enable development of commercially valuable plant lines
and related IP with stabilized genetics within two years
▪ Monetize our hemp/cannabis IP beginning in 2021 and
continue to bring disruptive technology forward
Maintain diligent financial execution, efficient
operating structure, and balance sheet strength
to support growth initiatives
02
04
I
22nd Century Group, Inc.
Support, advance, and advocate for FDA to
enact its proposed nicotine cap mandate for
all combustibles
▪ Favorable political climate for critical public
health initiatives
■
▪ Initial development of a third, plant-based
franchise in process
Operates in industry that is not as highly
regulated and legislated; faster route to
commercialization than first two franchises
■ Pursue strategic partnerships to support
development of this franchise
5View entire presentation